RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Clinical and genetic ancestry profile of a large multi-centre sickle cell disease cohort in Brazil
Carneiro-Proietti, A. B. F., Kelly, S., Miranda Teixeira, C., Sabino, E. C., Alencar, C. S., Capuani, L., Salomon Silva, T. P., Araujo, A., Loureiro, P., Máximo, C., Lobo, C., Flor-Park, M. V., Rodrigues, D. O. W., Mota, R. A., Gonçalez, T. T., Hoppe, C., Ferreira, J. E., Ozahata, M., Page, G. P., ... International Component of the NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III) (2018). Clinical and genetic ancestry profile of a large multi-centre sickle cell disease cohort in Brazil. British Journal of Haematology, 182(6), 895-908. https://doi.org/10.1111/bjh.15462
Approximately 3500 children with sickle cell disease (SCD) are born in Brazil each year, but the burden of SCD morbidity is not fully characterised. A large, multi-centre cohort was established to characterise clinical outcomes in the Brazilian SCD population and create the infrastructure to perform genotype-phenotype association studies. Eligible patients were randomly selected from participating sites and recruited at routine visits. A biorepository of blood samples was created and comprehensive demographic and clinical outcome data were entered in a centralized electronic database. Peripheral blood genome-wide single nucleotide polymorphism (SNP) genotyping was performed using a customized Transfusion Medicine (TM) Array. A total of 2795 participants at six Brazilian sites were enrolled between 2013 and 2015. The cohort included slight predominance of children <18 years (55·9%) and females (53·0%). Haemoglobin (Hb) SS was the most common SCD genotype (70·7%), followed by HbSC (23%), Sβ0 (3·0%) and Sβ+ (2·9%). SNP data from the TM Array were analysed to evaluate the genetic ancestry of the cohort and revealed significant admixture among the population. Demographics and clinical complications, stratified by age and SCD genotype, are summarized and future studies in this cohort are discussed.
